Newman et al. 5 found that DNA double-strand breakage contributes to human neuroblastoma and that the alternative (a)-NHEJ pathway involving LIG3 is a therapeutic target for high-risk neuroblastoma. The gene discussed is LIG3; the disease is neuroblastoma.